India's pharmaceutical exports are predicted to reach $27bn this fiscal year, boosted by strong US demand, despite concern over Indian-made cough syrups previously linked to scores of children's deaths. The robust forecast follows worries from the Indian government over dwindling global confidence in the quality of the country's pharma exports following the incidents in Gambia and Uzbekistan.
